A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer

NCT06562543 · clinicaltrials.gov ↗
PHASE4
Phase
RECRUITING
Status
78
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Takeda